Fevzi Çakmak Mahallesi, 10739. Sokak No:16 - 42050 - Karatay - KONYA
2012
It started its scientific and commercial activities in 2012 under the name of SEROPARK®.
Fevzi Çakmak Mahallesi, 10739. Sokak No:16 - 42050 - Karatay - KONYA
It started its scientific and commercial activities in 2012 under the name of SEROPARK®.
Established in Selçuk University Teknokent, SEROPARK® started to produce internal quality control materials based on the lyophilization of the whole blood/serum and plasma matrix of human origin, which has not yet been mass-produced in the country, with the Lyophilization technology it has based on its academic knowledge in its joint structure.
At that time, there was no legal basis for the supply of biological materials. In order to solve the problems encountered in the supply of necessary biological materials in production and R&D studies, With the very important contributions and support of the bureaucrats working within the Ministry of Health, important efforts were made to provide a legal basis for the biological material collection procedure to be used in the production of Internal and External Quality Control Material.
With the circular of the Republic of Turkiye Ministry of Health General Directorate of Health Services dated 28.10.2013 and numbered 2013/9 specifying the Procedures and Principles on Biological Material Supply Protocol from Public Institutions and Organizations Laboratories, a legal basis was established to be used in the production of Internal and External Quality Control Material.
In this period, ISO and CE certifications were completed by making trademark registrations (SEROPARK®, MULTICHECK®).
SEROPARK® started the first TUBITAK-1507 project within the scope of R&D activities, which is one of the main reasons for existence, while trying to meet the domestic requirement with its existing infrastructure.
The project titled "Production of Cardiac Control, ISD Control and Diabetes Control Internal Quality Control Material from Human Serum and Whole Blood Residues" (Project No: 7130140) was completed between 01.07.2013-31.12.2014. In the light of the information and findings obtained, the production phase was started for three control panels that are widely used and critical all over the world.
Continuing its R&D activities without slowing down, SEROPAK® started its second TUBITAK 1507 project in 2015. The project titled "Human Serum Based Sepsis, Tumor and Vitamin D Internal Control Production and Validation" (Project No: 7150085) was successfully completed between 01.07.2015-31.12.2016.
SEROCON®, which went into corporate operation in 2017
After a number of developments that took shape in the SEROPARK® company structure during this period, SEROCON® R&D Biotechnology Health Chemistry Industry Trading Co started its scientific and commercial activities on 11.01.2017 after the completion of the necessary registration procedures, based on past experience and experience, with the aim of protecting the existing know-how and infrastructure and meeting the field demands, a new structuring was made with the critically important stakeholders within SEROPARK®.
SEROCON®, which quickly carried its internal structuring to the corporate ground, primarily aimed to produce Domestic and Lyophilized External Quality Control Material in every aspect since its establishment by enriching the technical infrastructure and personnel portfolio while continuing the production of Domestic Quality Control Material uninterruptedly. SEROCHECK® and SEROQAS® trademarks were registered.
With the letter dated 14.01.2022 and numbered 185777870 sent by SEROCON® to the Republic of Turkiye Ministry of Health, authorization to collect biological materials for use in R&D and production activities was requested. In the reply dated 23.03.2022, it was reported that "SEROCON® R&D Biotechnology Health Chemistry Industry Trading Co can collect the biological material in question at the level of 81 Provincial Health and Provincial Public Health Directorates, which are under the responsibility of the Ministry, with the aim of producing Internal and External Quality Control Material in order to reduce our country's foreign dependence in the field of Biotechnology. With this official permission, SEROCON® has been authorized to collect the necessary biological material throughout Turkiye within the scope of production and R&D activities.
During this period, the necessary documentation procedure and software infrastructure, whose registration rights belong entirely to SEROCON®, were completed and TURKAK 17043 application was made in 2022. After the inspection in September 2022, the identified deficiencies were corrected. SEROCON® continues to provide Internal (SEROCHECK®) and External (SEROQAS®) Quality Control Material services to all its domestic and international stakeholders with the TÜRKAK 17043 accreditation it holds.